UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025912
Receipt number R000026482
Scientific Title Feasibility Study of Continuous Intervention with Designated Treatment Application for NASH (Non-Alcoholic Steatohepatitis) Patients
Date of disclosure of the study information 2017/01/31
Last modified on 2021/07/27 19:12:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility Study of Continuous Intervention with Designated Treatment Application for NASH (Non-Alcoholic Steatohepatitis) Patients

Acronym

Continuous Intervention of Application for NASH patients

Scientific Title

Feasibility Study of Continuous Intervention with Designated Treatment Application for NASH (Non-Alcoholic Steatohepatitis) Patients

Scientific Title:Acronym

Continuous Intervention of Application for NASH patients

Region

Japan


Condition

Condition

Non-Alcoholic Steatohepatitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigate the use rate of aid and intervention application for patients with Non-Alcoholic Steatohepatitis

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The use or achievement rate of program provided by application

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Intervention and aid application for improvement of non-alcoholic steatohepatitis

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients diagnosed as non-alcoholic steatohepatitis by clinical examinations including imageinspection and who agree to participate in the study after enough explanation about the study.

Key exclusion criteria

exclusion criteria
1. a patient does not agree
2. a patient who the attending physician think is does not seem able to use a smartphone.
3. pregnant patients.
4. patients with comorbid hepatitis (e.g., viral hepatitis, autoimmune hepatitis)

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryosuke Tateishi

Organization

The University of Tokyo

Division name

Cancer Professional Training Plan, Department of Gastroenterology

Zip code


Address

7-3-1, Hongo, Bunkyo-ku

TEL

+81-3-3815-5411

Email

tateishi-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masaya Sato

Organization

The University of Tokyo

Division name

Department of Clinical Laboratory Medicine , Department of Gastroenterology

Zip code


Address

7-3-1, Hongo, Bunkyo-ku

TEL

+81-3-3815-5411

Homepage URL


Email

satoma-tky@umin.ac.jp


Sponsor or person

Institute

Department of Gastroenterology, The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

CureApp, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.longdom.org/open-access/effect-of-smartphone-applicationenabled-daily-intervention-for-p

Number of participants that the trial has enrolled

9

Results

Since one patient was lost to follow-up, the comparison between pre- and post-intervention values was performed for 8 patients. A post-intervention weight reduction was observed in 7 patients, and this weight reduction was statistically significant (p=0.02).Normalization of the ALT level (<30 U/L) was observed in two patients.

Results date posted

2021 Year 07 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 25 Day

Date of IRB


Anticipated trial start date

2016 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 30 Day

Last modified on

2021 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026482


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name